May 15, 2018 – BrainQ, a Jerusalem-based digital therapeutics startup that aims to help stroke victims and those with spinal cord injuries treat their injuries with the help of a personalized electromagnetic treatment protocol, announced that it has raised a $5.3 million funding round on top of the $3.5 million the company previously raised. The company’s investors include Qure Ventures, crowdfunding platform OurCrowd.com, Norma Investments, IT-Farm and a number of angel investors, including Valtech Cardio founder and CEO Amir Gross.
BrainQ is working on two human clinical trials for stroke patients in Israel. At that time, the company had closed its first funding round and had also recently started to work with Google’s Launchpad Accelerator, too.
The general idea behind BrainQ is to use the patient’s brainwaves to generate a tailored treatment protocol. No AI company would be complete without data — it’s what drives these algorithms, after all — and the company says it owns one the largest Brain Computer Interface-based EEG databases for motor tasks. It’s that database that allows it to interpret the patient’s brain waves and generate its treatment protocol.
Source: Tedcrunch https://techcrunch.com/2018/05/15/brainq-raises-5-3m-to-treat-neurological-disorders-with-the-help-of-ai/